1-Jahres-Chart
5-Tage-Chart
| Realtime | Geld | Brief | Zeit |
|---|---|---|---|
| 0,206 | 0,268 | 11:15 |
- Alle
- Pressemitteilungen
- Empfehlungen
- Chartanalysen
- Berichte
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| NEEMS HILL Aktie jetzt für 0€ handeln | |||||
| 22.09. | NEEM S HILL AB: Neem's Hill - Building the Next Chapter | 1 | Cision News | ||
| 22.09. | Neem's Hill AB: Neem's Hill - Building the Next Chapter | 166 | GlobeNewswire (Europe) | Neem's Hill AB (publ) provides a shareholder update on the Group's development, highlighting an installed base now exceeding 60 vetIQure systems and more than 4,500 Animal Care treatments sold.FROM... ► Artikel lesen | |
| 11.08. | NEEM S HILL AB: Neem's Hill AB (publ) publishes Interim report Q2 2026 | 1 | Cision News | ||
| 11.08. | Neem's Hill AB: Neem's Hill AB (publ) publishes Interim report Q2 2026 | 605 | GlobeNewswire (Europe) | The report is attached to this press release and can also be downloaded from the company's website
January - June 2026
Net sales amounted to 6,090 KSEK (6,313)
Profit/loss after financial... ► Artikel lesen | |
| 13.07. | Neem's Hill AB: Scandinavian ChemoTech AB changes name to Neem's Hill AB | 333 | GlobeNewswire (Europe) | Former Scandinavian ChemoTech AB, has completed the name change to Neem's Hill AB ("Neem's Hill" or "the Company"), which was resolved at the Annual General Meeting held on 5 May 2026. The name change... ► Artikel lesen | |
| 10.07. | Change of issuer name for Scandinavian ChemoTech AB | 454 | GlobeNewswire | As from July 13, 2026, Scandinavian ChemoTech AB will change issuer name
Company name is Neem's Hill AB.
Old issuer name: Scandinavian ChemoTech AB
New issuer name: Neem's Hill AB
New... ► Artikel lesen | |
| 02.06. | Scandinavian ChemoTech AB: Scandinavian ChemoTech secures SEK 6 million Growth Loan from a larger Swedish Financial Institution | 238 | GlobeNewswire (Europe) | Scandinavian ChemoTech has secured a SEK 6 million growth loan from a larger financial institution in Sweden.
The financing forms part of ChemoTech's long-term financial strategy and will support the... ► Artikel lesen | |
| 28.04. | Scandinavian ChemoTech AB: Scandinavian ChemoTech AB (publ) publishes Interim report Q1 2026 | 353 | GlobeNewswire (Europe) | The report is attached to this press release and can also be downloaded from the company's website January - March 2026
Net sales amounted to 2,798 KSEK (2,472)
Profit/loss after... ► Artikel lesen | |
| 07.04. | Scandinavian ChemoTech AB: ChemoTech's Proposed Strategic Changes Accepted by Nasdaq First North | 261 | GlobeNewswire (Europe) | Scandinavian ChemoTech AB (publ) (the "Company") today announces that, based on information disclosed in the Company's press releases published on Tuesday, March 31, ahead of the notice of the Annual... ► Artikel lesen | |
| 01.04. | Scandinavian ChemoTech AB: Scandinavian ChemoTech Starts 2026 Strong with Best First Quarter in Company History | 266 | GlobeNewswire (Europe) | Scandinavian ChemoTech's Animal Care continues its strong commercial momentum, delivering its best first quarter in the company's history in Q1 2026, with sales amounting to approx. 299,000 USD compared... ► Artikel lesen | |
| 31.03. | Scandinavian ChemoTech AB: Scandinavian ChemoTech proposes expanded business activities, name change & received proposal on directed issue | 361 | GlobeNewswire (Europe) | NOT FOR DISCLOSURE, DISTRIBUTION OR PUBLICATION, IN WHOLE OR IN PART, DIRECTLY OR INDIRECTLY, IN OR TO THE UNITED STATES, AUSTRALIA, BELARUS, HONG KONG, JAPAN, CANADA, NEW ZEALAND, RUSSIA, SWITZERLAND... ► Artikel lesen | |
| 17.02. | Scandinavian ChemoTech AB: Scandinavian ChemoTech AB (publ) publishes Year-end report 2025 | 347 | GlobeNewswire (Europe) | The report is attached to this press release and can also be downloaded from the company's website.
October - December 2025
Net sales amounted to 2,648 KSEK (2,041)
Profit/loss after... ► Artikel lesen | |
| 05.01. | Scandinavian ChemoTech AB: New Year's Letter to Shareholders in Scandinavian ChemoTech - Reflecting on 2025 | 485 | GlobeNewswire (Europe) | Dear Shareholders,
As we enter 2026, I would like to thank you for your continued trust and support of Scandinavian ChemoTech. The past year, 2025, has been an important one for the Company, a year... ► Artikel lesen | |
| 04.11.25 | Scandinavian ChemoTech AB: Scandinavian ChemoTech AB (publ) publishes Interim Report Q3 2025 | 294 | GlobeNewswire (Europe) | The report is attached to this press release and can also be downloaded from the company's website.
July - September 2025 ... ► Artikel lesen | |
| 17.10.25 | Scandinavian ChemoTech AB: Scandinavian ChemoTech's Animal Care Surpasses 3,000 Treatments Performed Worldwide | 323 | GlobeNewswire (Europe) | Scandinavian ChemoTech's Animal Care, a pioneer in making oncology care more compassionate and human for animals, proudly announces another achievement: over 3,000 treatments have now been performed... ► Artikel lesen |
15 Nachrichten in den letzten 12 Monaten
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| ADAPTHEALTH | 6,065 | 0,00 % | Morning Market Movers: Ameresco, Inno Holdings, AdaptHealth, Ibotta See Big Swings | OTTAWA (dpa-AFX) - At 7:50 a.m. ET on Tuesday, premarket trading is seeing notable activity in several stocks, with early price movements signaling potential opportunities before the opening... ► Artikel lesen | |
| BRIGHTSPRING HEALTH SERVICES | 63,65 | 0,00 % | BMO Capital reiterates Outperform on BrightSpring Health stock | ||
| ALIGNMENT HEALTHCARE | 8,720 | +0,11 % | William Blair stuft Alignment Healthcare wegen Kostendruck und Rating-Herabstufung ab | ||
| HEARTFLOW | 47,590 | 0,00 % | Biotech Stocks At 52-Week Highs - Vaxcyte +31% On Phase 3 Results, InfuSystem, Illumina +7%, Charles River Laboratories +7%, HeartFlow +5% | SAN DIEGO (dpa-AFX) - The following biotech stocks reached a 52-week high on October 5, 2026, driven by key catalysts such as encouraging clinical research data.Vaxcyte Inc. (PCVX)Vaxcyte is... ► Artikel lesen | |
| BILLIONTOONE | 95,41 | 0,00 % | BillionToOne, Inc.: BillionToOne's Tissue-Free Northstar Response Demonstrates On-Par to Superior Cancer Treatment Monitoring vs. Tumor-Informed Assay, New Peer-Reviewed Study Finds | MENLO PARK, Calif., Oct. 07, 2026 (GLOBE NEWSWIRE) -- BillionToOne, Inc. (Nasdaq: BLLN), a next-generation molecular diagnostics company with a mission to create powerful and accurate tests that are... ► Artikel lesen | |
| FRESENIUS | 42,420 | +2,00 % | JEFFERIES stuft Fresenius SE auf 'Buy' | NEW YORK (dpa-AFX Analyser) - Das Analysehaus Jefferies hat die Einstufung für Fresenius vor einem Treffen mit dem Chef Michael Sen auf "Buy" mit einem Kursziel von 55 Euro belassen. Die geschäftliche... ► Artikel lesen | |
| PROGYNY | 27,820 | -0,04 % | Progyny expects 1.2 million new covered lives in 2027 | ||
| FRESENIUS MEDICAL CARE | 37,480 | +2,07 % | Fresenius Medical Care: Helen Giza verlässt den Konzern - Nachfolger steht fest | Bad Marienberg (www.anleihencheck.de) - Ad hoc-Mitteilung der Fresenius Medical Care AG vom 07.10.2026:Der Aufsichtsrat der Fresenius Medical Care AG hat heute einstimmig beschlossen, Shervin J. Korangy... ► Artikel lesen | |
| AVEANNA HEALTHCARE | 12,235 | 0,00 % | Aveanna Healthcare Holdings, Inc. - 8-K, Current Report | ||
| PRIVIA HEALTH GROUP | 20,180 | 0,00 % | Privia Health Group, Inc.: Privia Health to Report Third Quarter 2026 Results on Thursday, November 5 | ||
| GENEDX | 67,67 | 0,00 % | GeneDx: Starkes Wachstum trifft auf schwachen Forderungseinzug | ||
| LIFESTANCE HEALTH GROUP | 12,060 | 0,00 % | Transcript: LifeStance Health Gr Q2 2026 Earnings Conference Call | ||
| BETA BIONICS | 17,440 | 0,00 % | Beta Bionics, Inc.: Beta Bionics Announces Agreement Integrate the iLet Bionic Pancreas and mint with Senseonics' Eversense 365 | IRVINE, Calif., Sept. 22, 2026 (GLOBE NEWSWIRE) -- Beta Bionics, Inc. (Nasdaq: BBNX), a pioneering leader in the development of advanced diabetes management solutions, today announced a partnership... ► Artikel lesen | |
| CONCENTRA GROUP | 36,670 | 0,00 % | Why Concentra's Quiet Healthcare Business Keeps Winning | ||
| SIEMENS HEALTHINEERS | 38,710 | +1,18 % | EQS-CMS: Siemens Healthineers AG: Veröffentlichung einer Kapitalmarktinformation | EQS Zulassungsfolgepflichtmitteilung: Siemens Healthineers AG
/ Bekanntmachung nach Art. 5 Abs. 1 lit. b), Abs. 3 der Verordnung (EU) Nr. 596/2014, zuletzt geändert durch die Verordnung... ► Artikel lesen |
Das Unternehmen NEEMS HILL AB kann der Branche Gesundheitswesen zugeordnet werden. Die relative Kursveränderung beträgt aktuell 0,00 % bei einem Aktienkurs von 0,190 Euro.
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und sowie Kurse und Daten von ARIVA.DE AG.
Weitere Kennzahlen, Fundamentaldaten und Unternehmensinformationen zu NEEMS HILL AB finden Sie auf Wallstreet Online.